{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T10:08:23Z","timestamp":1775902103554,"version":"3.50.1"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T00:00:00Z","timestamp":1316476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00415-011-6240-5","type":"journal-article","created":{"date-parts":[[2011,9,19]],"date-time":"2011-09-19T15:06:45Z","timestamp":1316444805000},"page":"801-816","source":"Crossref","is-referenced-by-count":46,"title":["A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis"],"prefix":"10.1007","volume":"259","author":[{"given":"Christopher","family":"Eckstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiv","family":"Saidha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,20]]},"reference":[{"issue":"2","key":"6240_CR1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O\u2019Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302. doi: 10.1002\/ana.22366","journal-title":"Ann Neurol"},{"issue":"9","key":"6240_CR2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/1352458508096878","volume":"14","author":"DH Miller","year":"2008","unstructured":"Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, Galetta SL, Hutchinson M, Johnson RT, Kappos L, Kira J, Lublin FD, McFarland HF, Montalban X, Panitch H, Richert JR, Reingold SC, Polman CH (2008) Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 14(9):1157\u20131174. doi: 10.1177\/1352458508096878","journal-title":"Mult Scler"},{"issue":"6\u20137","key":"6240_CR3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0035-3787(07)90473-7","volume":"163","author":"J Seze de","year":"2007","unstructured":"de Seze J (2007) Multiple sclerosis: clinical aspects, acute disseminated encephalomyelitis, neuromyelitis optica and other inflammatory variants. Rev Neurol (Paris) 163(6\u20137):647\u2013650","journal-title":"Rev Neurol (Paris)"},{"issue":"6","key":"6240_CR4","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.braindev.2009.10.006","volume":"32","author":"H Torisu","year":"2010","unstructured":"Torisu H, Kira R, Ishizaki Y, Sanefuji M, Yamaguchi Y, Yasumoto S, Murakami Y, Shimono M, Nagamitsu S, Masuzaki M, Amamoto M, Kondo R, Uozumi T, Aibe M, Gondo K, Hanai T, Hirose S, Matsuishi T, Shirahata A, Mitsudome A, Hara T (2010) Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan. Brain Dev 32(6):454\u2013462. doi: 10.1016\/j.braindev.2009.10.006","journal-title":"Brain Dev"},{"key":"6240_CR5","first-page":"147","volume-title":"Clinical neuroimmunology","author":"A Tselis","year":"2005","unstructured":"Tselis A, Lisak R (2005) Acute disseminated encephalomyelitis. In: Antel JP, Birnbaum G, Hartung HP, Vincent A (eds) Clinical neuroimmunology. Oxford University Press, New York, pp 147\u2013171"},{"issue":"16 Suppl 2","key":"6240_CR6","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1212\/01.wnl.0000259422.44235.a8","volume":"68","author":"LB Krupp","year":"2007","unstructured":"Krupp LB, Banwell B, Tenembaum S (2007) Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 68(16 Suppl 2):S7\u2013S12. doi: 10.1212\/01.wnl.0000259422.44235.a8","journal-title":"Neurology"},{"issue":"3","key":"6240_CR7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clineuro.2005.11.017","volume":"108","author":"VV Brinar","year":"2006","unstructured":"Brinar VV, Poser CM (2006) The spectrum of disseminated encephalomyelitis. Clin Neurol Neurosurg 108(3):295\u2013310. doi: 10.1016\/j.clineuro.2005.11.017","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"6240_CR8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.clineuro.2004.02.004","volume":"106","author":"CM Poser","year":"2004","unstructured":"Poser CM, Brinar VV (2004) Diagnostic criteria for multiple sclerosis: an historical review. Clin Neurol Neurosurg 106(3):147\u2013158. doi: 10.1016\/j.clineuro.2004.02.004","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"6240_CR9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00234-004-1203-5","volume":"46","author":"W Kuker","year":"2004","unstructured":"Kuker W, Ruff J, Gaertner S, Mehnert F, Mader I, Nagele T (2004) Modern MRI tools for the characterization of acute demyelinating lesions: value of chemical shift and diffusion-weighted imaging. Neuroradiology 46(6):421\u2013426. doi: 10.1007\/s00234-004-1203-5","journal-title":"Neuroradiology"},{"issue":"11","key":"6240_CR10","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/01.wnl.0000338630.20412.45","volume":"72","author":"DJ Callen","year":"2009","unstructured":"Callen DJ, Shroff MM, Branson HM, Li DK, Lotze T, Stephens D, Banwell BL (2009) Role of MRI in the differentiation of ADEM from MS in children. Neurology 72(11):968\u2013973. doi: 10.1212\/01.wnl.0000338630.20412.45","journal-title":"Neurology"},{"issue":"1","key":"6240_CR11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00247-009-1372-9","volume":"40","author":"L Ben Sira","year":"2010","unstructured":"Ben Sira L, Miller E, Artzi M, Fattal-Valevski A, Constantini S, Ben Bashat D (2010) 1H-MRS for the diagnosis of acute disseminated encephalomyelitis: insight into the acute-disease stage. Pediatr Radiol 40(1):106\u2013113. doi: 10.1007\/s00247-009-1372-9","journal-title":"Pediatr Radiol"},{"issue":"6","key":"6240_CR12","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00115-004-1842-0","volume":"76","author":"O Stuve","year":"2005","unstructured":"Stuve O, Nessler S, Hartung HP, Hemmer B, Wiendl H, Kieseier BC (2005) Acute disseminated encephalomyelitis: pathogenesis, diagnosis, treatment, and prognosis. Nervenarzt 76(6):701\u2013707. doi: 0.1007\/s00115-004-1842-0","journal-title":"Nervenarzt"},{"issue":"1\u20132","key":"6240_CR13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2008.06.004","volume":"200","author":"D Franciotta","year":"2008","unstructured":"Franciotta D, Columba-Cabezas S, Andreoni L, Ravaglia S, Jarius S, Romagnolo S, Tavazzi E, Bergamaschi R, Zardini E, Aloisi F, Marchioni E (2008) Oligoclonal IgG band patterns in inflammatory demyelinating human and mouse diseases. J Neuroimmunol 200(1\u20132):125\u2013128. doi: 10.1016\/j.jneuroim.2008.06.004","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"6240_CR14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneuroim.2006.06.028","volume":"180","author":"M Reindl","year":"2006","unstructured":"Reindl M, Khalil M, Berger T (2006) Antibodies as biological markers for pathophysiological processes in MS. J Neuroimmunol 180(1\u20132):50\u201362. doi: 10.1016\/j.jneuroim.2006.06.028","journal-title":"J Neuroimmunol"},{"issue":"3","key":"6240_CR15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/1352458510389220","volume":"17","author":"PH Lalive","year":"2011","unstructured":"Lalive PH, Hausler MG, Maurey H, Mikaeloff Y, Tardieu M, Wiendl H, Schroeter M, Hartung HP, Kieseier BC, Menge T (2011) Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children. Mult Scler 17(3):297\u2013302. doi: 10.1177\/1352458510389220","journal-title":"Mult Scler"},{"issue":"5","key":"6240_CR16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejpn.2004.05.006","volume":"8","author":"M Tardieu","year":"2004","unstructured":"Tardieu M, Mikaeloff Y (2004) What is acute disseminated encephalomyelitis (ADEM)? Eur J Paediatr Neurol 8(5):239\u2013242. doi: 10.1016\/j.ejpn.2004.05.006","journal-title":"Eur J Paediatr Neurol"},{"key":"6240_CR17","first-page":"419","volume-title":"Neuropathology","author":"M Rodriguez","year":"1983","unstructured":"Rodriguez M, Powell H, Lampert W (1983) Demyelination and leukodystrophy in the clinical neurosciences. In: Rosenberg R, Schoclet S (eds) Neuropathology, vol III. Churchill Livinstone, New York, pp 419\u2013443"},{"issue":"4","key":"6240_CR18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jca.2920070403","volume":"7","author":"RB Stricker","year":"1992","unstructured":"Stricker RB, Miller RG, Kiprov DD (1992) Role of plasmapheresis in acute disseminated (post-infectious) encephalomyelitis. J Clin Apher 7(4):173\u2013179","journal-title":"J Clin Apher"},{"issue":"4","key":"6240_CR19","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1212\/WNL.49.4.1145","volume":"49","author":"J Straub","year":"1997","unstructured":"Straub J, Chofflon M, Delavelle J (1997) Early high-dose intravenous methylprednisolone in acute disseminated encephalomyelitis: a successful recovery. Neurology 49(4):1145\u20131147","journal-title":"Neurology"},{"issue":"6 Suppl 5","key":"6240_CR20","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.51.6_Suppl_5.S2","volume":"51","author":"MC Dalakas","year":"1998","unstructured":"Dalakas MC (1998) Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases. Neurology 51(6 Suppl 5):S2\u2013S8","journal-title":"Neurology"},{"issue":"6","key":"6240_CR21","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1212\/WNL.54.6.1370","volume":"54","author":"DJ Sahlas","year":"2000","unstructured":"Sahlas DJ, Miller SP, Guerin M, Veilleux M, Francis G (2000) Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology 54(6):1370\u20131372","journal-title":"Neurology"},{"issue":"6","key":"6240_CR22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/088307389501000612","volume":"10","author":"M Kleiman","year":"1995","unstructured":"Kleiman M, Brunquell P (1995) Acute disseminated encephalomyelitis: response to intravenous immunoglobulin. J Child Neurol 10(6):481\u2013483","journal-title":"J Child Neurol"},{"key":"6240_CR23","unstructured":"Bala B, Banwell B (2010) Cognitive and behavioural outcomes in individuals with a history of childhood acute disseminated encephalomyelitis. 62nd Annual Meeting, American Academy of Neurology, Toronto, pp IN2-2.005"},{"issue":"3","key":"6240_CR24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/02841850902736617","volume":"50","author":"FY Donmez","year":"2009","unstructured":"Donmez FY, Aslan H, Coskun M (2009) Evaluation of possible prognostic factors of fulminant acute disseminated encephalomyelitis (ADEM) on magnetic resonance imaging with fluid-attenuated inversion recovery (FLAIR) and diffusion-weighted imaging. Acta Radiol 50(3):334\u2013339. doi: 10.1080\/02841850902736617","journal-title":"Acta Radiol"},{"issue":"18","key":"6240_CR25","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1212\/01.wnl.0000264553.99997.45","volume":"68","author":"BL Banwell","year":"2007","unstructured":"Banwell BL (2007) The long (-itudinally extensive) and the short of it: transverse myelitis in children. Neurology 68(18):1447\u20131449. doi: 10.1212\/01.wnl.0000264553.99997.45","journal-title":"Neurology"},{"issue":"10","key":"6240_CR26","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/WNL.56.10.1313","volume":"56","author":"S Schwarz","year":"2001","unstructured":"Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Hagenlocher B (2001) Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 56(10):1313\u20131318","journal-title":"Neurology"},{"issue":"10","key":"6240_CR27","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485\u20131489. doi: 10.1212\/01.wnl.0000216139.44259.74","journal-title":"Neurology"},{"issue":"1\u20132","key":"6240_CR28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jneuroim.2007.04.009","volume":"187","author":"A Jacob","year":"2007","unstructured":"Jacob A, Matiello M, Wingerchuk DM, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) Neuromyelitis optica: changing concepts. J Neuroimmunol 187(1\u20132):126\u2013138. doi: 10.1016\/j.jneuroim.2007.04.009","journal-title":"J Neuroimmunol"},{"issue":"9","key":"6240_CR29","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6(9):805\u2013815. doi: 10.1016\/S1474-4422(07)70216-8","journal-title":"Lancet Neurol"},{"issue":"5","key":"6240_CR30","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O\u2019Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology 53(5):1107\u20131114","journal-title":"Neurology"},{"issue":"1","key":"6240_CR31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00415-004-0271-0","volume":"251","author":"A Ghezzi","year":"2004","unstructured":"Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E, Mancardi L, Gallo P, Filippi M, Zaffaroni M, Comi G (2004) Clinical characteristics, course and prognosis of relapsing Devic\u2019s Neuromyelitis Optica. J Neurol 251(1):47\u201352. doi: 10.1007\/s00415-004-0271-0","journal-title":"J Neurol"},{"issue":"18","key":"6240_CR32","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","volume":"76","author":"N Asgari","year":"2011","unstructured":"Asgari N, Lillevang ST, Skejoe HP, Falah M, Stenager E, Kyvik KO (2011) A population-based study of neuromyelitis optica in Caucasians. Neurology 76(18):1589\u20131595. doi: 10.1212\/WNL.0b013e3182190f74","journal-title":"Neurology"},{"issue":"7","key":"6240_CR33","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.63.7.964","volume":"63","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA (2006) Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63(7):964\u2013968. doi: 10.1001\/archneur.63.7.964","journal-title":"Arch Neurol"},{"issue":"4","key":"6240_CR34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202(4):473\u2013477. doi: 10.1084\/jem.20050304","journal-title":"J Exp Med"},{"issue":"9451","key":"6240_CR35","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364(9451):2106\u20132112. doi: 10.1016\/S0140-6736(04)17551-X","journal-title":"Lancet"},{"issue":"1","key":"6240_CR36","first-page":"27","volume":"3","author":"C Eckstein","year":"2011","unstructured":"Eckstein C, Syc S, Saidha S (2011) Differential diagnosis of longitudinally extensive transverse myelitis in adults. Eur Neurol J 3(1):27\u201339","journal-title":"Eur Neurol J"},{"issue":"1\u20132","key":"6240_CR37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jns.2007.09.010","volume":"266","author":"T Matsuoka","year":"2008","unstructured":"Matsuoka T, Matsushita T, Osoegawa M, Ochi H, Kawano Y, Mihara F, Ohyagi Y, Kira J (2008) Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings. J Neurol Sci 266(1\u20132):115\u2013125","journal-title":"J Neurol Sci"},{"issue":"2","key":"6240_CR38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1474-4422(03)00308-9","volume":"2","author":"J Kira","year":"2003","unstructured":"Kira J (2003) Multiple sclerosis in the Japanese population. Lancet Neurol 2(2):117\u2013127","journal-title":"Lancet Neurol"},{"issue":"9","key":"6240_CR39","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/jnnp.2005.080390","volume":"77","author":"I Nakashima","year":"2006","unstructured":"Nakashima I, Fujihara K, Miyazawa I, Misu T, Narikawa K, Nakamura M, Watanabe S, Takahashi T, Nishiyama S, Shiga Y, Sato S, Weinshenker BG, Itoyama Y (2006) Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 77(9):1073\u20131075. doi: 10.1136\/jnnp.2005.080390","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"6240_CR40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1474-4422(06)70333-7","volume":"5","author":"BG Weinshenker","year":"2006","unstructured":"Weinshenker BG, Wingerchuk DM, Nakashima I, Fujihara K, Lennon VA (2006) OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol 5(2):110\u2013111","journal-title":"Lancet Neurol"},{"key":"6240_CR41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1196\/annals.1444.002","volume":"1142","author":"J Kira","year":"2008","unstructured":"Kira J (2008) Neuromyelitis optica and Asian phenotype of multiple sclerosis. Ann N Y Acad Sci 1142:58\u201371","journal-title":"Ann N Y Acad Sci"},{"issue":"Pt 7","key":"6240_CR42","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H (2002) A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain 125(Pt 7):1450\u20131461","journal-title":"Brain"},{"issue":"Pt 5","key":"6240_CR43","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","volume":"130","author":"SF Roemer","year":"2007","unstructured":"Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF (2007) Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130(Pt 5):1194\u20131205. doi: 10.1093\/brain\/awl371","journal-title":"Brain"},{"issue":"Pt 5","key":"6240_CR44","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","volume":"130","author":"T Misu","year":"2007","unstructured":"Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y (2007) Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130(Pt 5):1224\u20131234. doi: 10.1093\/brain\/awm047","journal-title":"Brain"},{"issue":"2","key":"6240_CR45","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/1352458506070732","volume":"13","author":"C Papeix","year":"2007","unstructured":"Papeix C, Vidal JS, de Seze J, Pierrot-Deseilligny C, Tourbah A, Stankoff B, Lebrun C, Moreau T, Vermersch P, Fontaine B, Lyon-Caen O, Gout O (2007) Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 13(2):256\u2013259. doi: 10.1177\/1352458506070732","journal-title":"Mult Scler"},{"issue":"7","key":"6240_CR46","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","volume":"64","author":"BA Cree","year":"2005","unstructured":"Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64(7):1270\u20131272. doi: 10.1212\/01.WNL.0000159399.81861.D5","journal-title":"Neurology"},{"issue":"4","key":"6240_CR47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10072-007-0823-z","volume":"28","author":"M Capobianco","year":"2007","unstructured":"Capobianco M, Malucchi S, di Sapio A, Gilli F, Sala A, Bottero R, Marnetto F, Doriguzzi Bozzo C, Bertolotto A (2007) Variable responses to rituximab treatment in neuromyelitis optica (Devic\u2019s disease). Neurol Sci 28(4):209\u2013211. doi: 10.1007\/s10072-007-0823-z","journal-title":"Neurol Sci"},{"key":"6240_CR48","doi-asserted-by":"crossref","unstructured":"Kim SH, Kim W, Li XF, Jung IJ, Kim HJ (2011) Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2\u00a0years. Arch Neurol. doi: 10.1001\/archneurol.2011.154","DOI":"10.1001\/archneurol.2011.154"},{"issue":"15","key":"6240_CR49","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1212\/WNL.0b013e3182152881","volume":"76","author":"HL Pellkofer","year":"2011","unstructured":"Pellkofer HL, Krumbholz M, Berthele A, Hemmer B, Gerdes LA, Havla J, Bittner R, Canis M, Meinl E, Hohlfeld R, Kuempfel T (2011) Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab. Neurology 76(15):1310\u20131315. doi: 10.1212\/WNL.0b013e3182152881","journal-title":"Neurology"},{"issue":"1\u20132","key":"6240_CR50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jneuroim.2005.01.024","volume":"168","author":"O Neuhaus","year":"2005","unstructured":"Neuhaus O, Wiendl H, Kieseier BC, Archelos JJ, Hemmer B, Stuve O, Hartung HP (2005) Multiple sclerosis: mitoxantrone promotes differential effects on immunocompetent cells in vitro. J Neuroimmunol 168(1\u20132):128\u2013137. doi: 10.1016\/j.jneuroim.2005.01.024","journal-title":"J Neuroimmunol"},{"issue":"1","key":"6240_CR51","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2249.2005.02653.x","volume":"139","author":"A Chan","year":"2005","unstructured":"Chan A, Weilbach FX, Toyka KV, Gold R (2005) Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients. Clin Exp Immunol 139(1):152\u2013158. doi: 10.1111\/j.1365-2249.2005.02653.x","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"6240_CR52","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.4049\/jimmunol.178.10.6092","volume":"178","author":"M Duddy","year":"2007","unstructured":"Duddy M, Niino M, Adatia F, Hebert S, Freedman M, Atkins H, Kim HJ, Bar-Or A (2007) Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol 178(10):6092\u20136099","journal-title":"J Immunol"},{"issue":"4","key":"6240_CR53","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/archneurol.2010.322","volume":"68","author":"SH Kim","year":"2011","unstructured":"Kim SH, Kim W, Park MS, Sohn EH, Li XF, Kim HJ (2011) Efficacy and safety of mitoxantrone in patients with highly relapsing neuromyelitis optica. Arch Neurol 68(4):473\u2013479. doi: 10.1001\/archneurol.2010.322","journal-title":"Arch Neurol"},{"issue":"2","key":"6240_CR54","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00415-007-0730-5","volume":"255","author":"Y Shimizu","year":"2008","unstructured":"Shimizu Y, Yokoyama K, Misu T, Takahashi T, Fujihara K, Kikuchi S, Itoyama Y, Iwata M (2008) Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis. J Neurol 255(2):305\u2013307. doi: 10.1007\/s00415-007-0730-5","journal-title":"J Neurol"},{"issue":"1","key":"6240_CR55","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","volume":"65","author":"SJ Pittock","year":"2008","unstructured":"Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zephir H, Moder K, Weinshenker BG (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65(1):78\u201383. doi: 10.1001\/archneurol.2007.17","journal-title":"Arch Neurol"},{"issue":"1","key":"6240_CR56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.nrl.0000250927.21903.f8","volume":"13","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM (2007) Diagnosis and treatment of neuromyelitis optica. Neurologist 13(1):2\u201311. doi: 10.1097\/01.nrl.0000250927.21903.f8","journal-title":"Neurologist"},{"issue":"4","key":"6240_CR57","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/WNL.59.4.499","volume":"59","author":"Transverse Myelitis Consortium Working Group","year":"2002","unstructured":"Transverse Myelitis Consortium Working Group (2002) Proposed diagnostic criteria, nosology of acute transverse myelitis. Neurology 59(4):499\u2013505","journal-title":"Neurology"},{"issue":"11","key":"6240_CR58","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1177\/1352458509345906","volume":"15","author":"J Young","year":"2009","unstructured":"Young J, Quinn S, Hurrell M, Taylor B (2009) Clinically isolated acute transverse myelitis: prognostic features and incidence. Mult Scler 15(11):1295\u20131302. doi: 10.1177\/1352458509345906","journal-title":"Mult Scler"},{"key":"6240_CR59","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/archneur.1963.00460080021002","volume":"9","author":"PH Altrocchi","year":"1963","unstructured":"Altrocchi PH (1963) Acute transverse myelopathy. Arch Neurol 9:111\u2013119","journal-title":"Arch Neurol"},{"issue":"12","key":"6240_CR60","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000188896.48308.26","volume":"65","author":"J Seze de","year":"2005","unstructured":"de Seze J, Lanctin C, Lebrun C, Malikova I, Papeix C, Wiertlewski S, Pelletier J, Gout O, Clerc C, Moreau C, Defer G, Edan G, Dubas F, Vermersch P (2005) Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology 65(12):1950\u20131953. doi: 10.1212\/01.wnl.0000188896.48308.26","journal-title":"Neurology"},{"issue":"2","key":"6240_CR61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1191\/135248506ms1260oa","volume":"12","author":"J Bruna","year":"2006","unstructured":"Bruna J, Martinez-Yelamos S, Martinez-Yelamos A, Rubio F, Arbizu T (2006) Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases. Mult Scler 12(2):169\u2013173","journal-title":"Mult Scler"},{"issue":"6","key":"6240_CR62","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00415-009-5450-6","volume":"257","author":"MP Alvarenga","year":"2010","unstructured":"Alvarenga MP, Thuler LC, Neto SP, Vasconcelos CC, Camargo SG, Papais-Alvarenga RM (2010) The clinical course of idiopathic acute transverse myelitis in patients from Rio de Janeiro. J Neurol 257(6):992\u2013998. doi: 10.1007\/s00415-009-5450-6","journal-title":"J Neurol"},{"issue":"18","key":"6240_CR63","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1212\/01.wnl.0000260609.11357.6f","volume":"68","author":"FS Pidcock","year":"2007","unstructured":"Pidcock FS, Krishnan C, Crawford TO, Salorio CF, Trovato M, Kerr DA (2007) Acute transverse myelitis in childhood: center-based analysis of 47 cases. Neurology 68(18):1474\u20131480. doi: 10.1212\/01.wnl.0000260609.11357.6f","journal-title":"Neurology"},{"issue":"1","key":"6240_CR64","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00415-007-0686-5","volume":"255","author":"J Perumal","year":"2008","unstructured":"Perumal J, Zabad R, Caon C, MacKenzie M, Tselis A, Bao F, Latif Z, Zak I, Lisak R, Khan O (2008) Acute transverse myelitis with normal brain MRI: long-term risk of MS. J Neurol 255(1):89\u201393. doi: 10.1007\/s00415-007-0686-5","journal-title":"J Neurol"},{"issue":"6","key":"6240_CR65","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0404.2007.00835.x","volume":"115","author":"TF Scott","year":"2007","unstructured":"Scott TF (2007) Nosology of idiopathic transverse myelitis syndromes. Acta Neurol Scand 115(6):371\u2013376. doi: 10.1111\/j.1600-0404.2007.00835.x","journal-title":"Acta Neurol Scand"},{"issue":"Pt 1","key":"6240_CR66","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/brain\/116.1.135","volume":"116","author":"SP Morrissey","year":"1993","unstructured":"Morrissey SP, Miller DH, Kendall BE, Kingsley DP, Kelly MA, Francis DA, MacManus DG, McDonald WI (1993) The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis: a 5-year follow-up study. Brain 116(Pt 1):135\u2013146","journal-title":"Brain"},{"issue":"5","key":"6240_CR67","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/135245850000600503","volume":"6","author":"K Bashir","year":"2000","unstructured":"Bashir K, Whitaker JN (2000) Importance of para-clinical and CSF studies in the diagnosis of MS in patients presenting with partial cervical transverse myelopathy and negative cranial MRI. Mult Scler 6(5):312\u2013316","journal-title":"Mult Scler"},{"issue":"8","key":"6240_CR68","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1468-1331.2006.01376.x","volume":"13","author":"KH Chan","year":"2006","unstructured":"Chan KH, Tsang KL, Fong GC, Ho SL, Cheung RT, Mak W (2006) Idiopathic inflammatory demyelinating disorders after acute transverse myelitis. Eur J Neurol 13(8):862\u2013868. doi: 10.1111\/j.1468-1331.2006.01376.x","journal-title":"Eur J Neurol"},{"issue":"1","key":"6240_CR69","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.nrl.0000149975.39201.0b","volume":"11","author":"AI Kaplin","year":"2005","unstructured":"Kaplin AI, Krishnan C, Deshpande DM, Pardo CA, Kerr DA (2005) Diagnosis and management of acute myelopathies. Neurologist 11(1):2\u201318. doi: 10.1097\/01.nrl.0000149975.39201.0b","journal-title":"Neurologist"},{"key":"6240_CR70","doi-asserted-by":"crossref","unstructured":"Borchers AT, Gershwin ME (2011) Transverse myelitis. Autoimmun Rev. doi: 10.1016\/j.autrev.2011.05.018","DOI":"10.1016\/j.autrev.2011.05.018"},{"issue":"4","key":"6240_CR71","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/archneur.1973.00490220060009","volume":"28","author":"HL Lipton","year":"1973","unstructured":"Lipton HL, Teasdall RD (1973) Acute transverse myelopathy in adults: a follow-up study. Arch Neurol 28(4):252\u2013257","journal-title":"Arch Neurol"},{"issue":"10","key":"6240_CR72","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1172\/JCI25141","volume":"115","author":"AI Kaplin","year":"2005","unstructured":"Kaplin AI, Deshpande DM, Scott E, Krishnan C, Carmen JS, Shats I, Martinez T, Drummond J, Dike S, Pletnikov M, Keswani SC, Moran TH, Pardo CA, Calabresi PA, Kerr DA (2005) IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Invest 115(10):2731\u20132741. doi: 10.1172\/JCI25141","journal-title":"J Clin Invest"},{"issue":"1","key":"6240_CR73","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-2007-1019132","volume":"28","author":"A Jacob","year":"2008","unstructured":"Jacob A, Weinshenker BG (2008) An approach to the diagnosis of acute transverse myelitis. Semin Neurol 28(1):105\u2013120. doi: 10.1055\/s-2007-1019132","journal-title":"Semin Neurol"},{"issue":"19","key":"6240_CR74","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1212\/01.wnl.0000260970.63493.c8","volume":"68","author":"BM Greenberg","year":"2007","unstructured":"Greenberg BM, Thomas KP, Krishnan C, Kaplin AI, Calabresi PA, Kerr DA (2007) Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide. Neurology 68(19):1614\u20131617. doi: 10.1212\/01.wnl.0000260970.63493.c8","journal-title":"Neurology"},{"issue":"6","key":"6240_CR75","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","volume":"46","author":"BG Weinshenker","year":"1999","unstructured":"Weinshenker BG, O\u2019Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, Pineda AA, Stevens LN, Rodriguez M (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46(6):878\u2013886","journal-title":"Ann Neurol"},{"issue":"4","key":"6240_CR76","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/1352458508100837","volume":"15","author":"M Bonnan","year":"2009","unstructured":"Bonnan M, Valentino R, Olindo S, Mehdaoui H, Smadja D, Cabre P (2009) Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder. Mult Scler 15(4):487\u2013492. doi: 10.1177\/1352458508100837","journal-title":"Mult Scler"},{"issue":"6","key":"6240_CR77","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554\u2013558","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"6240_CR78","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1177\/1352458509106636","volume":"15","author":"SM Kim","year":"2009","unstructured":"Kim SM, Waters P, Vincent A, Kim SY, Kim HJ, Hong YH, Park KS, Min JH, Sung JJ, Lee KW (2009) Sj\u00f6gren\u2019s syndrome myelopathy: spinal cord involvement in Sj\u00f6gren\u2019s syndrome might be a manifestation of neuromyelitis optica. Mult Scler 15(9):1062\u20131068. doi: 10.1177\/1352458509106636","journal-title":"Mult Scler"},{"issue":"9","key":"6240_CR79","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1177\/1352458509106636","volume":"15","author":"SM Kim","year":"2009","unstructured":"Kim SM, Waters P, Vincent A, Kim SY, Kim HJ, Hong YH, Park KS, Min JH, Sung JJ, Lee KW (2009) Sj\u00f6gren\u2019s syndrome myelopathy: spinal cord involvement in Sj\u00f6gren\u2019s syndrome might be a manifestation of neuromyelitis optica. Mult Scler 15(9):1062\u20131068","journal-title":"Mult Scler"},{"issue":"3","key":"6240_CR80","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1191\/1352458503ms905oa","volume":"9","author":"I Pericot","year":"2003","unstructured":"Pericot I, Brieva L, Tintore M, Rio J, Sastre-Garriga J, Nos C, Montalban X (2003) Myelopathy in seronegative Sj\u00f6gren syndrome and\/or primary progressive multiple sclerosis. Mult Scler 9(3):256\u2013259","journal-title":"Mult Scler"},{"issue":"5","key":"6240_CR81","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","volume":"83","author":"S Delalande","year":"2004","unstructured":"Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, Dubucquoi S, Pruvo JP, Vermersch P, Hatron PY (2004) Neurologic manifestations in primary Sj\u00f6gren syndrome: a study of 82 patients. Medicine (Baltimore) 83(5):280\u2013291","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"6240_CR82","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/rheumatology\/27.4.275","volume":"27","author":"A Binder","year":"1988","unstructured":"Binder A, Snaith ML, Isenberg D (1988) Sj\u00f6gren\u2019s syndrome: a study of its neurological complications. Br J Rheumatol 27(4):275\u2013280","journal-title":"Br J Rheumatol"},{"issue":"6","key":"6240_CR83","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0025-6196(11)62408-7","volume":"76","author":"SR Pillemer","year":"2001","unstructured":"Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ 3rd, O\u2019Fallon WM, Fox PC (2001) Incidence of physician-diagnosed primary Sj\u00f6gren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc 76(6):593\u2013599","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"6240_CR84","doi-asserted-by":"crossref","first-page":"323","DOI":"10.7326\/0003-4819-104-3-323","volume":"104","author":"EL Alexander","year":"1986","unstructured":"Alexander EL, Malinow K, Lejewski JE, Jerdan MS, Provost TT, Alexander GE (1986) Primary Sj\u00f6gren\u2019s syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med 104(3):323\u2013330","journal-title":"Ann Intern Med"},{"issue":"5","key":"6240_CR85","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/archneur.58.5.815","volume":"58","author":"CS Williams","year":"2001","unstructured":"Williams CS, Butler E, Roman GC (2001) Treatment of myelopathy in Sj\u00f6gren syndrome with a combination of prednisone and cyclophosphamide. Arch Neurol 58(5):815\u2013819","journal-title":"Arch Neurol"},{"issue":"1","key":"6240_CR86","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1385\/CRIAI:25:1:3","volume":"25","author":"S Jimenez","year":"2003","unstructured":"Jimenez S, Cervera R, Font J, Ingelmo M (2003) The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol 25(1):3\u201312. doi: 10.1385\/CRIAI:25:1:3","journal-title":"Clin Rev Allergy Immunol"},{"key":"6240_CR87","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jnnp.2009.200071","volume":"10","author":"FG Joseph","year":"2010","unstructured":"Joseph FG, Scolding N (2010) Neurolupus. Pract Neurol 10:4\u201315","journal-title":"Pract Neurol"},{"issue":"3","key":"6240_CR88","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0049-0172(79)80009-8","volume":"8","author":"SG Ellis","year":"1979","unstructured":"Ellis SG, Verity MA (1979) Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955\u20131977. Semin Arthritis Rheum 8(3):212\u2013221","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"6240_CR89","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.59.2.120","volume":"59","author":"B Kovacs","year":"2000","unstructured":"Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ (2000) Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 59(2):120\u2013124","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"6240_CR90","first-page":"985","volume":"30","author":"G Sanna","year":"2003","unstructured":"Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A, Hughes GR (2003) Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 30(5):985\u2013992","journal-title":"J Rheumatol"},{"issue":"4","key":"6240_CR91","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.semarthrit.2008.09.002","volume":"39","author":"G Espinosa","year":"2010","unstructured":"Espinosa G, Mendizabal A, Minguez S, Ramo-Tello C, Capellades J, Olive A, Cervera R (2010) Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients. Semin Arthritis Rheum 39(4):246\u2013256. doi: 10.1016\/j.semarthrit.2008.09.002","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"6240_CR92","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10067-002-8287-2","volume":"21","author":"Y Sherer","year":"2002","unstructured":"Sherer Y, Hassin S, Shoenfeld Y, Levy Y, Livneh A, Ohry A, Langevitz P (2002) Transverse myelitis in patients with antiphospholipid antibodies\u2013the importance of early diagnosis and treatment. Clin Rheumatol 21(3):207\u2013210","journal-title":"Clin Rheumatol"},{"issue":"9","key":"6240_CR93","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. doi: 10.1002\/1529-0131(199709)40:9<1725:AID-ART29>3.0.CO;2-Y","journal-title":"Arthritis Rheum"},{"issue":"9","key":"6240_CR94","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/rheumatology\/31.9.619","volume":"31","author":"P Creamer","year":"1992","unstructured":"Creamer P, Kirwan J (1992) Seronegative systemic lupus erythematosus. Br J Rheumatol 31(9):619\u2013622","journal-title":"Br J Rheumatol"},{"issue":"1","key":"6240_CR95","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jnnp.2009.200071","volume":"10","author":"FG Joseph","year":"2010","unstructured":"Joseph FG, Scolding NJ (2010) Neurolupus. Pract Neurol 10(1):4\u201315. doi: 10.1136\/jnnp.2009.200071","journal-title":"Pract Neurol"},{"issue":"6","key":"6240_CR96","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/ard.48.6.512","volume":"48","author":"DJ Propper","year":"1989","unstructured":"Propper DJ, Bucknall RC (1989) Acute transverse myelopathy complicating systemic lupus erythematosus. Ann Rheum Dis 48(6):512\u2013515","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6240_CR97","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.21483","volume":"64","author":"S Appenzeller","year":"2008","unstructured":"Appenzeller S, Vasconcelos Faria A, Li LM, Costallat LT, Cendes F (2008) Quantitative magnetic resonance imaging analyses and clinical significance of hyperintense white matter lesions in systemic lupus erythematosus patients. Ann Neurol 64(6):635\u2013643. doi: 10.1002\/ana.21483","journal-title":"Ann Neurol"},{"issue":"12","key":"6240_CR98","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1191\/0961203303lu498oa","volume":"12","author":"JW Graham","year":"2003","unstructured":"Graham JW, Jan W (2003) MRI and the brain in systemic lupus erythematosus. Lupus 12(12):891\u2013896","journal-title":"Lupus"},{"issue":"1","key":"6240_CR99","first-page":"89","volume":"17","author":"DT Boumpas","year":"1990","unstructured":"Boumpas DT, Patronas NJ, Dalakas MC, Hakim CA, Klippel JH, Balow JE (1990) Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature. J Rheumatol 17(1):89\u201392","journal-title":"J Rheumatol"},{"issue":"4","key":"6240_CR100","first-page":"389","volume":"12","author":"A Salmaggi","year":"1994","unstructured":"Salmaggi A, Lamperti E, Eoli M, Venegoni E, Bruzzone MG, Riccio G, La Mantia L (1994) Spinal cord involvement and systemic lupus erythematosus: clinical and magnetic resonance findings in 5 patients. Clin Exp Rheumatol 12(4):389\u2013394","journal-title":"Clin Exp Rheumatol"},{"key":"6240_CR101","first-page":"CD002265","volume":"2","author":"VF Trevisani","year":"2006","unstructured":"Trevisani VF, Castro AA, Neves Neto JF, Atallah AN (2006) Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus. Cochrane Database Syst Rev 2:CD002265. doi: 10.1002\/14651858.CD002265.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"6240_CR102","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2004.025528","volume":"64","author":"L Barile-Fabris","year":"2005","unstructured":"Barile-Fabris L, Ariza-Andraca R, Olguin-Ortega L, Jara LJ, Fraga-Mouret A, Miranda-Limon JM, Fuentes de la Mata J, Clark P, Vargas F, Alocer-Varela J (2005) Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis 64(4):620\u2013625. doi: 10.1136\/ard.2004.025528","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"6240_CR103","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/art.24068","volume":"59","author":"PR Fortin","year":"2008","unstructured":"Fortin PR, Abrahamowicz M, Ferland D, Lacaille D, Smith CD, Zummer M (2008) Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 59(12):1796\u20131804. doi: 10.1002\/art.24068","journal-title":"Arthritis Rheum"},{"issue":"5","key":"6240_CR104","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2215\/CJN.01200307","volume":"2","author":"M Walsh","year":"2007","unstructured":"Walsh M, James M, Jayne D, Tonelli M, Manns BJ, Hemmelgarn BR (2007) Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2(5):968\u2013975. doi: 10.2215\/CJN.01200307","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"6240_CR105","first-page":"167","volume":"119","author":"A Perry","year":"1995","unstructured":"Perry A, Vuitch F (1995) Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 119(2):167\u2013172","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"6240_CR106","first-page":"113","volume":"152","author":"C Chapelon-Abric","year":"2001","unstructured":"Chapelon-Abric C (2001) Neurosarcoidosis. Ann Med Interne (Paris) 152(2):113\u2013124","journal-title":"Ann Med Interne (Paris)"},{"issue":"9","key":"6240_CR107","first-page":"10","volume":"7","author":"DG James","year":"1967","unstructured":"James DG (1967) Sarcoidosis. Curr Med Drugs 7(9):10\u201321","journal-title":"Curr Med Drugs"},{"issue":"3","key":"6240_CR108","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","volume":"145","author":"BA Rybicki","year":"1997","unstructured":"Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC (1997) Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 145(3):234\u2013241","journal-title":"Am J Epidemiol"},{"issue":"4","key":"6240_CR109","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1055\/s-0030-1262210","volume":"31","author":"DL Vargas","year":"2010","unstructured":"Vargas DL, Stern BJ (2010) Neurosarcoidosis: diagnosis and management. Semin Respir Crit Care Med 31(4):419\u2013427. doi: 10.1055\/s-0030-1262210","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"6240_CR110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/qjmed\/92.2.103","volume":"92","author":"JP Zajicek","year":"1999","unstructured":"Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, Scadding JW, Thompson EJ, Chamoun V, Miller DH, McDonald WI, Mitchell D (1999) Central nervous system sarcoidosis\u2013diagnosis and management. Qjm 92(2):103\u2013117","journal-title":"Qjm"},{"issue":"7","key":"6240_CR111","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1474-4422(04)00805-1","volume":"3","author":"E Hoitsma","year":"2004","unstructured":"Hoitsma E, Faber CG, Drent M, Sharma OP (2004) Neurosarcoidosis: a clinical dilemma. Lancet Neurol 3(7):397\u2013407. doi: 10.1016\/S1474-4422(04)00805-1","journal-title":"Lancet Neurol"},{"key":"6240_CR112","doi-asserted-by":"crossref","unstructured":"Lower EE, Weiss KL (2008) Neurosarcoidosis. Clin Chest Med 29 (3):475\u2013492, ix. doi: 10.1016\/j.ccm.2008.03.016","DOI":"10.1016\/j.ccm.2008.03.016"},{"issue":"9","key":"6240_CR113","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archneur.1985.04060080095022","volume":"42","author":"BJ Stern","year":"1985","unstructured":"Stern BJ, Krumholz A, Johns C, Scott P, Nissim J (1985) Sarcoidosis and its neurological manifestations. Arch Neurol 42(9):909\u2013917","journal-title":"Arch Neurol"},{"issue":"2","key":"6240_CR114","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MD.0b013e3181d5c6b4","volume":"89","author":"F Cohen-Aubart","year":"2010","unstructured":"Cohen-Aubart F, Galanaud D, Grabli D, Haroche J, Amoura Z, Chalpelon-Abric C, Lyon-Caen O, Valeyre D, Piette JC (2010) Spinal cord sarcoidosis: clinical and laboratory profile and outcome of 31 patients in a case-control study. Medicine (Baltimore) 89(2):133\u2013140","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"6240_CR115","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0025-6196(11)65143-4","volume":"74","author":"JC Dale","year":"1999","unstructured":"Dale JC, O\u2019Brien JF (1999) Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis. Mayo Clin Proc 74(5):535","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"6240_CR116","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1378\/chest.117.4.931","volume":"117","author":"RP Baughman","year":"2000","unstructured":"Baughman RP, Iannuzzi MC (2000) Diagnosis of sarcoidosis: when is a peek good enough? Chest 117(4):931\u2013932","journal-title":"Chest"},{"issue":"1","key":"6240_CR117","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2133.2003.05042.x","volume":"148","author":"DJ Kouba","year":"2003","unstructured":"Kouba DJ, Mimouni D, Rencic A, Nousari HC (2003) Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis. Br J Dermatol 148(1):147\u2013148","journal-title":"Br J Dermatol"},{"issue":"5","key":"6240_CR118","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1378\/chest.124.5.2023","volume":"124","author":"JD Doty","year":"2003","unstructured":"Doty JD, Mazur JE, Judson MA (2003) Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest 124(5):2023\u20132026","journal-title":"Chest"},{"issue":"4","key":"6240_CR119","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.amjmed.2004.03.013","volume":"117","author":"JD Carter","year":"2004","unstructured":"Carter JD, Valeriano J, Vasey FB, Bognar B (2004) Refractory neurosarcoidosis: a dramatic response to infliximab. Am J Med 117(4):277\u2013279","journal-title":"Am J Med"},{"issue":"4","key":"6240_CR120","first-page":"662","volume":"22","author":"GF Duna","year":"1995","unstructured":"Duna GF, Calabrese LH (1995) Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system. J Rheumatol 22(4):662\u2013667","journal-title":"J Rheumatol"},{"issue":"8697","key":"6240_CR121","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease (1990) Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet 335(8697):1078\u20131080","journal-title":"Lancet"},{"issue":"1","key":"6240_CR122","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00002281-200101000-00004","volume":"13","author":"H Yazici","year":"2001","unstructured":"Yazici H, Yurdakul S, Hamuryudan V (2001) Beh\u00e7et disease. Curr Opin Rheumatol 13(1):18\u201322","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"6240_CR123","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00019052-200406000-00017","volume":"17","author":"A Siva","year":"2004","unstructured":"Siva A, Altintas A, Saip S (2004) Beh\u00e7et\u2019s syndrome and the nervous system. Curr Opin Neurol 17(3):347\u2013357","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"6240_CR124","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1474-4422(09)70015-8","volume":"8","author":"A Al-Araji","year":"2009","unstructured":"Al-Araji A, Kidd DP (2009) Neuro-Beh\u00e7et\u2019s disease: epidemiology, clinical characteristics, and management. Lancet Neurol 8(2):192\u2013204","journal-title":"Lancet Neurol"},{"issue":"12","key":"6240_CR125","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.jocn.2009.06.002","volume":"16","author":"GM Mullins","year":"2009","unstructured":"Mullins GM, Elamin M, Saidha S, Ali E, Jennings L, Counihan TJ, Hennessy M (2009) Acute aseptic meningitis and diffuse myelitis as the presenting features of neurological Beh\u00e7et disease. J Clin Neurosci 16(12):1702\u20131704. doi: 10.1016\/j.jocn.2009.06.002","journal-title":"J Clin Neurosci"},{"issue":"Pt 11","key":"6240_CR126","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","volume":"122","author":"G Akman-Demir","year":"1999","unstructured":"Akman-Demir G, Serdaroglu P, Tasci B (1999) Clinical patterns of neurological involvement in Beh\u00e7et\u2019s disease: evaluation of 200 patients: the Neuro-Beh\u00e7et study group. Brain 122(Pt 11):2171\u20132182","journal-title":"Brain"},{"issue":"4","key":"6240_CR127","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s004150050205","volume":"245","author":"P Serdaroglu","year":"1998","unstructured":"Serdaroglu P (1998) Beh\u00e7et\u2019s disease and the nervous system. J Neurol 245(4):197\u2013205","journal-title":"J Neurol"},{"issue":"Pt 11","key":"6240_CR128","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/brain\/122.11.2183","volume":"122","author":"D Kidd","year":"1999","unstructured":"Kidd D, Steuer A, Denman AM, Rudge P (1999) Neurological complications in Beh\u00e7et\u2019s syndrome. Brain 122(Pt 11):2183\u20132194","journal-title":"Brain"},{"issue":"1\u20132","key":"6240_CR129","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2003.08.040","volume":"145","author":"G Saruhan-Direskeneli","year":"2003","unstructured":"Saruhan-Direskeneli G, Yentur SP, Akman-Demir G, Isik N, Serdaroglu P (2003) Cytokines and chemokines in neuro-Beh\u00e7et\u2019s disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol 145(1\u20132):127\u2013134","journal-title":"J Neuroimmunol"},{"issue":"3","key":"6240_CR130","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ncprheum0436","volume":"3","author":"H Yazici","year":"2007","unstructured":"Yazici H, Fresko I, Yurdakul S (2007) Beh\u00e7et\u2019s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 3(3):148\u2013155","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"2","key":"6240_CR131","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s004150170242","volume":"248","author":"A Siva","year":"2001","unstructured":"Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, Kocer N, Yazici H (2001) Beh\u00e7et\u2019s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 248(2):95\u2013103","journal-title":"J Neurol"},{"issue":"6","key":"6240_CR132","first-page":"1015","volume":"20","author":"N Kocer","year":"1999","unstructured":"Kocer N, Islak C, Siva A, Saip S, Akman C, Kantarci O, Hamuryudan V (1999) CNS involvement in neuro-Beh\u00e7et syndrome: an MR study. AJNR Am J Neuroradiol 20(6):1015\u20131024","journal-title":"AJNR Am J Neuroradiol"},{"issue":"7","key":"6240_CR133","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1468-1331.2007.01754.x","volume":"14","author":"N Yesilot","year":"2007","unstructured":"Yesilot N, Mutlu M, Gungor O, Baykal B, Serdaroglu P, Akman-Demir G (2007) Clinical characteristics and course of spinal cord involvement in Beh\u00e7et\u2019s disease. Eur J Neurol 14(7):729\u2013737","journal-title":"Eur J Neurol"},{"issue":"2","key":"6240_CR134","first-page":"85","volume":"20","author":"D Kidd","year":"2003","unstructured":"Kidd D, Beynon HL (2003) The neurological complications of systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 20(2):85\u201394","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1\u20132","key":"6240_CR135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2008.05.002","volume":"272","author":"H Kikuchi","year":"2008","unstructured":"Kikuchi H, Aramaki K, Hirohata S (2008) Effect of infliximab in progressive neuro-Beh\u00e7et\u2019s syndrome. J Neurol Sci 272(1\u20132):99\u2013105","journal-title":"J Neurol Sci"},{"issue":"5","key":"6240_CR136","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11940-000-0042-x","volume":"2","author":"A Siva","year":"2000","unstructured":"Siva A, Fresko II (2000) Beh\u00e7et\u2019s disease. Curr Treat Options Neurol 2(5):435\u2013448","journal-title":"Curr Treat Options Neurol"},{"issue":"5","key":"6240_CR137","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ana.21226","volume":"62","author":"C Salvarani","year":"2007","unstructured":"Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Weigand SD, Miller DV, Giannini C, Meschia JF, Huston J 3rd, Hunder GG (2007) Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 62(5):442\u2013451","journal-title":"Ann Neurol"},{"issue":"1","key":"6240_CR138","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00002281-200401000-00009","volume":"16","author":"S Benseler","year":"2004","unstructured":"Benseler S, Schneider R (2004) Central nervous system vasculitis in children. Curr Opin Rheumatol 16(1):43\u201350","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"6240_CR139","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1474-4422(11)70081-3","volume":"10","author":"RA Hajj-Ali","year":"2011","unstructured":"Hajj-Ali RA, Singhal AB, Benseler S, Molloy E, Calabrese LH (2011) Primary angiitis of the CNS. Lancet Neurol 10(6):561\u2013572. doi: 10.1016\/S1474-4422(11)70081-3","journal-title":"Lancet Neurol"},{"issue":"7","key":"6240_CR140","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/1529-0131(199707)40:7<1189::AID-ART2>3.0.CO;2-4","volume":"40","author":"LH Calabrese","year":"1997","unstructured":"Calabrese LH, Duna GF, Lie JT (1997) Vasculitis in the central nervous system. Arthritis Rheum 40(7):1189\u20131201","journal-title":"Arthritis Rheum"},{"issue":"11","key":"6240_CR141","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/rheumatology\/ken328","volume":"47","author":"C Salvarani","year":"2008","unstructured":"Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF, Giannini C, Miller DV, Hunder GG (2008) Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy. Rheumatology (Oxford) 47(11):1671\u20131677","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"6240_CR142","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0046-8177(92)90238-X","volume":"23","author":"JT Lie","year":"1992","unstructured":"Lie JT (1992) Primary (granulomatous) angiitis of the central nervous system: a clinicopathologic analysis of 15 new cases and a review of the literature. Hum Pathol 23(2):164\u2013171","journal-title":"Hum Pathol"},{"issue":"1","key":"6240_CR143","first-page":"75","volume":"20","author":"MG Pomper","year":"1999","unstructured":"Pomper MG, Miller TJ, Stone JH, Tidmore WC, Hellmann DB (1999) CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography. AJNR Am J Neuroradiol 20(1):75\u201385","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"6240_CR144","first-page":"317","volume":"15","author":"KG Harris","year":"1994","unstructured":"Harris KG, Tran DD, Sickels WJ, Cornell SH, Yuh WT (1994) Diagnosing intracranial vasculitis: the roles of MR and angiography. AJNR Am J Neuroradiol 15(2):317\u2013330","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6 Suppl 32","key":"6240_CR145","first-page":"S127","volume":"21","author":"LH Calabrese","year":"2003","unstructured":"Calabrese LH (2003) Clinical management issues in vasculitis: angiographically defined angiitis of the central nervous system\u2014diagnostic and therapeutic dilemmas. Clin Exp Rheumatol 21(6 Suppl 32):S127\u2013S130","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"6240_CR146","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/archneur.1993.00540090032007","volume":"50","author":"TL Vollmer","year":"1993","unstructured":"Vollmer TL, Guarnaccia J, Harrington W, Pacia SV, Petroff OA (1993) Idiopathic granulomatous angiitis of the central nervous system: diagnostic challenges. Arch Neurol 50(9):925\u2013930","journal-title":"Arch Neurol"},{"issue":"6","key":"6240_CR147","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archneurol.2009.76","volume":"66","author":"J Birnbaum","year":"2009","unstructured":"Birnbaum J, Hellmann DB (2009) Primary angiitis of the central nervous system. Arch Neurol 66(6):704\u2013709","journal-title":"Arch Neurol"},{"issue":"8455","key":"6240_CR148","first-page":"586","volume":"2","author":"JA Levy","year":"1985","unstructured":"Levy JA, Shimabukuro J, Hollander H, Mills J, Kaminsky L (1985) Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet 2(8455):586\u2013588","journal-title":"Lancet"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-6240-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-011-6240-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-6240-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:22:55Z","timestamp":1559056975000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-011-6240-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,20]]},"references-count":148,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["6240"],"URL":"https:\/\/doi.org\/10.1007\/s00415-011-6240-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,20]]}}}